University of California (Irvine) Allergy and Immunology

Residency · Orange, CA

Sponsored by University of California (Irvine) · Director Yesim Demirdag

Works by its people: 671
Authors: 23
First-author works: 276
Citations: 22,439

20112026

Topics

Immunodeficiency and Autoimmune Disorders 137
Immune Cell Function and Interaction 46
T-cell and B-cell Immunology 35
Drug Transport and Resistance Mechanisms 20
Coagulation, Bradykinin, Polyphosphates, and Angioedema 17
Monoclonal and Polyclonal Antibodies Research 17
Asthma and respiratory diseases 15
Immunotherapy and Immune Responses 15
Ion channel regulation and function 15
Cell death mechanisms and regulation 14
Immune Response and Inflammation 14
HIV Research and Treatment 13

Most cited

Coronavirus disease 2019 in patients with inborn errors of immunity: An international study.
The Journal of allergy and clinical immunology · 2021 · 284 citations · Yesim Demirdag, Sudhir Gupta
Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet (London, England) · 2022 · 59 citations · Donald Levy
Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trial.
Journal of the peripheral nervous system : JPNS · 2023 · 34 citations · Leman Yel
Health-related quality of life in primary immunodeficiencies: Impact of delayed diagnosis and treatment burden.
Clinical immunology (Orlando, Fla.) · 2022 · 49 citations · Donald Levy
Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study.
The Lancet. Haematology · 2024 · 21 citations · Donald Levy
An expert panel's review on patients with hereditary angioedema switching from attenuated androgens to oral prophylactic therapy.
Allergy and asthma proceedings · 2024 · 14 citations · Donald Levy
Safety and Feasibility of Peanut, Tree Nut, and Sesame Oral Immunotherapy in Infants and Toddlers in a Real-World Setting.
The journal of allergy and clinical immunology. In practice · 2025 · 10 citations · Kevin Cook
Comparison of Old and New Systemic Treatments for Moderate to Severe Atopic Dermatitis.
Current allergy and asthma reports · 2024 · 16 citations · Tiffany Jean

Topics

Immunodeficiency and Autoimmune Disorders 137

Immune Cell Function and Interaction 46

T-cell and B-cell Immunology 35

Drug Transport and Resistance Mechanisms 20

Coagulation, Bradykinin, Polyphosphates, and Angioedema 17

Monoclonal and Polyclonal Antibodies Research 17

Asthma and respiratory diseases 15

Immunotherapy and Immune Responses 15

Ion channel regulation and function 15

Cell death mechanisms and regulation 14

Immune Response and Inflammation 14

HIV Research and Treatment 13

Most cited

Coronavirus disease 2019 in patients with inborn errors of immunity: An international study.

The Journal of allergy and clinical immunology · 2021 · 284 citations · Yesim Demirdag, Sudhir Gupta

Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial.

Lancet (London, England) · 2022 · 59 citations · Donald Levy

Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trial.

Journal of the peripheral nervous system : JPNS · 2023 · 34 citations · Leman Yel

Health-related quality of life in primary immunodeficiencies: Impact of delayed diagnosis and treatment burden.

Clinical immunology (Orlando, Fla.) · 2022 · 49 citations · Donald Levy

Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study.

The Lancet. Haematology · 2024 · 21 citations · Donald Levy

An expert panel's review on patients with hereditary angioedema switching from attenuated androgens to oral prophylactic therapy.

Allergy and asthma proceedings · 2024 · 14 citations · Donald Levy

Safety and Feasibility of Peanut, Tree Nut, and Sesame Oral Immunotherapy in Infants and Toddlers in a Real-World Setting.

The journal of allergy and clinical immunology. In practice · 2025 · 10 citations · Kevin Cook

Comparison of Old and New Systemic Treatments for Moderate to Severe Atopic Dermatitis.

Current allergy and asthma reports · 2024 · 16 citations · Tiffany Jean